Indirect costs in idiopathic Parkinson's disease

被引:8
作者
Barth, F
Baum, B
Bremen, D
Meuser, T
Jost, WH
机构
[1] Deutsch Klin Diagnost, D-65191 Wiesbaden, Germany
[2] Europa Fachhochschule Fresenius, Idstein, Germany
[3] Or Pharm GmbH, Hamburg, Germany
关键词
D O I
10.1055/s-2004-830106
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The economic impact of parkinsonism has been getting more significant due to the increasing prevalence of Parkinson's disease and the modern therapies available nowadays. The present study is supposed to update the existing databases and to provide a sound foundation for rational decision-making in the health care sector. It does not only focus on the direct costs of this disease incurred by 75 patients over a longer period, but also and for the first time, takes a look on the indirect cost as well. The study shows that the expenses for PD-related house rebuilding and early retirement make up for a substantial share among the indirect costs. In the overall analysis, the ratio between both, direct and indirect costs appear to be relatively balanced with slight domination of the direct costs.
引用
收藏
页码:187 / 191
页数:9
相关论文
共 8 条
[1]  
BREYER F, 1997, GESUNDHEITSOKONOMIE, V2
[2]   The economic impact of Parkinson's disease - An estimation based on a 3-month prospective analysis [J].
Dodel, RC ;
Singer, M ;
Kohne-Volland, R ;
Szucs, T ;
Rathay, B ;
Scholz, E ;
Oertel, WH .
PHARMACOECONOMICS, 1998, 14 (03) :299-312
[3]  
GREINER W, 1996, HOMO OECONOMICUS, V13, P167
[4]  
*HANN KONS, 1999, GES QUAL, pA62
[5]   Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease [J].
Iskedjian, M ;
Einarson, TR .
PHARMACOECONOMICS, 2003, 21 (02) :115-127
[6]  
JOST W, 2003, THERAPIE IDIOPATHISC
[7]  
KESSLER T, 2003, GRUNDBEGRIFFE GESUND, V30, P271
[8]  
RYCHLICK R, 1999, GESUNDHEITSOKONOMIE